Literature DB >> 7657298

Endothelin association with the cultured rat Kupffer cell: characterization and regulation.

K Stephenson1, S A Harvey, S B Mustafa, A T Eakes, M S Olson.   

Abstract

Circulating endothelin (ET) levels are elevated in conditions such as endotoxemia, hepatic ischemia-reperfusion injury, or orthotopic liver transplantation, and this potent peptide may contribute to hepatic pathophysiology. We measured the surface binding of [125I]ET-1 to rat Kupffer cells in primary culture at 4 degrees C; the dissociation constant (Kd) was 270 pmol/L, and the apparent Bmax was 3,000 receptors/cell. At 37 degrees C, total association (surface binding plus internalization) was much greater than at 4 degrees C, indicating that internalization of the receptor-ligand complex is rapid; the apparent Kd was 30 pmol/L, comparable with other reports for hepatic-derived cells. Studies using [125I]ET-1, [125I]ET-3, and specific ET (ant)agonists showed that Kupffer cells possess predominantly ET(B) type receptors. Prior treatment with 500 pmol/L unlabeled endothelin rapidly ( < 15 minutes) occluded 60% of subsequent [125I]ET association; using 5 nmol/L unlabeled ET, this occlusion occurred within 1 minute. [125I]ET association with Kupffer cells was unaffected by short-term (approximately 1 hour) treatment with cyclic adenosine monophosphate (cAMP), but long-term (20 hour) treatment resulted in a twofold increase in [125I]ET association with no change in the apparent Kd. Stimulation of protein kinase C in Kupffer cells by phorbol 12-myristate acetate had a dual regulatory effect on [125I]ET association. Short-term ( < 1 hour) treatment with phorbol 12-myristate acetate decreased [125I]ET-3 association by 50%, whereas prolonged treatment (20 hour) increased association twofold. In both cases, the apparent Kd for [125I]-endothelin was unaltered.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657298

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  4 in total

1.  Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver.

Authors:  H Yokomori; M Oda; Y Yasogawa; Y Nishi; M Ogi; M Takahashi; H Ishii
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

2.  An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation.

Authors:  Norihito Watanabe; Shinji Takashimizu; Yasuhiro Nishizaki; Seiichiro Kojima; Tatehiro Kagawa; Shohei Matsuzaki
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

3.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

4.  The serum endothelin-1 level in steatosis and NASH, and its relation with severity of liver fibrosis.

Authors:  Bulent Degertekin; Seren Ozenirler; Sehri Elbeg; Gulen Akyol
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.